REQUEST A DEMO
Total
USD $0.00
Search more companies

Medipiel S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Medipiel S.A.S. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Medipiel S.A.S. is an enterprise located in Colombia, with the main office in Medellin. It operates in the Pharmacies and Drug Stores sector. It was first established on September 08, 2003. 500 (2024) employees currently work for Medipiel S.A.S.. The latest financial highlights indicate a net sales revenue increase of 51.37% in 2023. Its’ total assets recorded a growth of 80.23%. The net profit margin of Medipiel S.A.S. decreased by 2.97% in 2023.

Headquarters
Calle 16 55 129 Piso 4
Medellin; Antioquia;

Contact Details: Purchase the Medipiel S.A.S. report to view the information.

Website: http://medipiel.com.co

Basic Information
Total Employees:
Purchase the Medipiel S.A.S. report to view the information.
Outstanding Shares:
Purchase the Medipiel S.A.S. report to view the information.
Incorporation Date:
September 08, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Medipiel S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
51.37%
Total operating revenue
49.59%
Net Profit (Loss) for the Period
2.26%
Total assets
80.23%
Total equity
96.04%
Net Profit Margin
-2.97%
Return on Equity (ROE)
-44.93%
Quick Ratio
0.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?